| scholarly article | Q13442814 |
| P50 | author | Frank Claessens | Q39418841 |
| P2093 | author name string | Annemie Haelens | |
| Leen Callewaert | |||
| Sarah Denayer | |||
| Tamzin Tanner | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4514-4523 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor | |
| P478 | volume | 67 |
| Q83047013 | A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels |
| Q37210787 | A novel androgen receptor amino terminal region reveals two classes of amino/carboxyl interaction-deficient variants with divergent capacity to activate responsive sites in chromatin |
| Q26747094 | A sting in the tail: the N-terminal domain of the androgen receptor as a drug target |
| Q34671957 | Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: circadian rhythm-associated alterations of glucocorticoid actions in target tissues |
| Q39338812 | Allosteric conversation in the androgen receptor ligand-binding domain surfaces. |
| Q39499483 | Analysis of interdomain interactions of the androgen receptor |
| Q92410955 | Androgen Receptor Dependence |
| Q50930950 | Androgen receptor association with mitotic chromatin - analysis with introduced deletions and disease-inflicting mutations. |
| Q42573875 | Androgen receptor signalling in prostate cancer: the functional consequences of acetylation |
| Q36003940 | Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal |
| Q30577613 | Androgen receptor splice variants determine taxane sensitivity in prostate cancer |
| Q36063723 | Androgen receptor: structure, role in prostate cancer and drug discovery |
| Q57105312 | Androgen receptor: what we know and what we expect in castration-resistant prostate cancer |
| Q55357541 | Androgen-Induced Immunosuppression. |
| Q30385279 | Androgens and the male reproductive tract: an overview of classical roles and current perspectives. |
| Q37435253 | B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy |
| Q34163679 | Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291. |
| Q30495758 | Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant |
| Q35226077 | Challenges in clinical and laboratory diagnosis of androgen insensitivity syndrome: a case report |
| Q91111834 | Communication between the Ligand-Binding Pocket and the Activation Function-2 Domain of Androgen Receptor Revealed by Molecular Dynamics Simulations |
| Q33658855 | Comparing the rules of engagement of androgen and glucocorticoid receptors |
| Q57108090 | Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer |
| Q60919540 | Digoxin, an Overlooked Agonist of RORγ/RORγT |
| Q37210875 | Diverse roles of androgen receptor (AR) domains in AR-mediated signaling |
| Q34112728 | Estrogen receptor mutations and changes in downstream gene expression and signaling |
| Q34869190 | Evidence on how a conserved glycine in the hinge region of HapR regulates its DNA binding ability: lessons from a natural variant |
| Q28242579 | Expression of Tubb3, a beta-tubulin isotype, is regulated by androgens in mouse and rat Sertoli cells |
| Q36733740 | Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD |
| Q38285293 | Functions of the Hsp90-binding FKBP immunophilins. |
| Q36978594 | HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. |
| Q48651888 | Healthy birth after testicular extraction of sperm and ICSI from an azoospermic man with mild androgen insensitivity syndrome caused by an androgen receptor partial loss-of-function mutation |
| Q38213505 | Hepatocyte nuclear factor-4α, a multifunctional nuclear receptor associated with cardiovascular disease and cholesterol catabolism. |
| Q42437930 | Immunostaining of the androgen receptor and sequence analysis of its DNA-binding domain in canine prostate cancer |
| Q40044845 | Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell |
| Q41364734 | Lysine acetyltransferases cyclic adenosine monophosphate response element-binding binding protein and acetyltransferase p300 attenuate transcriptional activity of the mineralocorticoid receptor through its acetylation |
| Q33632070 | Minireview: The versatile roles of lysine deacetylases in steroid receptor signaling |
| Q37899974 | Neurotoxic effects of androgens in spinal and bulbar muscular atrophy. |
| Q37697163 | PC-1 works in conjunction with E3 ligase CHIP to regulate androgen receptor stability and activity |
| Q34070890 | Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity |
| Q38836469 | Polyglutamine androgen receptor-mediated neuromuscular disease |
| Q57477979 | Predicting puberty in partial androgen insensitivity syndrome: Use of clinical and functional androgen receptor indices |
| Q38417890 | Proline-Directed Androgen Receptor Phosphorylation |
| Q39642231 | Regulation of the androgen receptor by SET9-mediated methylation |
| Q36579764 | Regulatory function of the P295-T311 motif of the estrogen receptor alpha - does proteasomal degradation of the receptor induce emergence of peptides implicated in estrogenic responses? |
| Q30352713 | SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. |
| Q35624126 | Structural and functional analysis of domains of the progesterone receptor |
| Q37637859 | Structure of the homodimeric androgen receptor ligand-binding domain |
| Q40293980 | Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity |
| Q37983462 | The androgen/androgen receptor axis in prostate cancer |
| Q34189517 | The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity |
| Q57169333 | The nuclear receptor superfamily: A structural perspective |
| Q33699615 | The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention |
| Q44091233 | The quantitative assessment of the role played by basic amino acid clusters in the nuclear uptake of human ribosomal protein L7. |
| Q37590123 | The role of androgen receptor mutations in prostate cancer progression. |
| Q39725189 | The rules of DNA recognition by the androgen receptor. |
| Q39170197 | The transcription intermediary factor 1β coactivates the androgen receptor. |
| Q80697262 | [Role of androgen receptors in hormone-refractory prostate cancer: molecular basics and experimental therapy approaches] |
Search more.